295 related articles for article (PubMed ID: 31423424)
1. Bone alterations in inflammatory bowel diseases.
Sgambato D; Gimigliano F; De Musis C; Moretti A; Toro G; Ferrante E; Miranda A; De Mauro D; Romano L; Iolascon G; Romano M
World J Clin Cases; 2019 Aug; 7(15):1908-1925. PubMed ID: 31423424
[TBL] [Abstract][Full Text] [Related]
2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
3. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
4. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.
Ghishan FK; Kiela PR
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G191-201. PubMed ID: 21088237
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
Jahnsen J; Falch JA; Aadland E; Mowinckel P
Gut; 1997 Mar; 40(3):313-9. PubMed ID: 9135518
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for osteoporosis in inflammatory bowel disease patients.
Lima CA; Lyra AC; Rocha R; Santana GO
World J Gastrointest Pathophysiol; 2015 Nov; 6(4):210-8. PubMed ID: 26600979
[TBL] [Abstract][Full Text] [Related]
7. Examination, prevention and treatment of osteoporosis in patients with inflammatory bowel disease: recommendations and reality.
Kirchgatterer A; Wenzl HH; Aschl G; Hinterreiter M; Stadler B; Hinterleitner TA; Petritsch W; Knoflach P
Acta Med Austriaca; 2002; 29(4):120-3. PubMed ID: 12424936
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease and the risk of osteoporosis and fracture.
Targownik LE; Bernstein CN; Leslie WD
Maturitas; 2013 Dec; 76(4):315-9. PubMed ID: 24139749
[TBL] [Abstract][Full Text] [Related]
9. Opportunistic screening for bone disease using abdominal CT scans obtained for other reasons in newly diagnosed IBD patients.
Rebello D; Anjelly D; Grand DJ; Machan JT; Beland MD; Furman MS; Shapiro J; LeLeiko N; Sands BE; Mallette M; Bright R; Moniz H; Merrick M; Shah SA
Osteoporos Int; 2018 Jun; 29(6):1359-1366. PubMed ID: 29520605
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology and the pathogenesis of inflammatory bowel disease.
Karlinger K; Györke T; Makö E; Mester A; Tarján Z
Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
[TBL] [Abstract][Full Text] [Related]
12. Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain.
Miranda-Bautista J; Verdejo C; Díaz-Redondo A; Bretón I; Bellón JM; Pérez-Valderas MD; Caballero-Marcos A; de Dios-Lascuevas M; González-Río E; García-Sánchez C; Marín-Jiménez I; Bañares R; Menchén L
Therap Adv Gastroenterol; 2019; 12():1756284819862152. PubMed ID: 31391867
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
Szymczak-Tomczak A; Krela-Kaźmierczak I; Kaczmarek-Ryś M; Hryhorowicz S; Stawczyk-Eder K; Szalata M; Skrzypczak-Zielińska M; Łykowska-Szuber L; Eder P; Michalak M; Dobrowolska A; Słomski R
Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
[TBL] [Abstract][Full Text] [Related]
14. Bone metabolism in inflammatory bowel diseases 1.
Kupka T; Svoboda P; Bojková M; Blaho M; Vašura A; Hrabovský V; Dítě P
Vnitr Lek; 2020; 66(7):3-7. PubMed ID: 33380127
[TBL] [Abstract][Full Text] [Related]
15. Bone Metabolism in Inflammatory Bowel Diseases 2.
Kupka T; Svoboda P; Bojková M; Blaho M; Vašura A; Hrabovský V; Dítě P
Vnitr Lek; 2020; 66(7):432-436. PubMed ID: 33380122
[TBL] [Abstract][Full Text] [Related]
16. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease.
Schulte C; Dignass AU; Mann K; Goebell H
Inflamm Bowel Dis; 1998 Nov; 4(4):268-75. PubMed ID: 9836078
[TBL] [Abstract][Full Text] [Related]
17. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
18. Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease.
Kotze LM; Costa CT; Cavassani MF; Nisihara RM
Rev Assoc Med Bras (1992); 2017 Jan; 63(1):13-17. PubMed ID: 28225873
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of osteoporosis in inflammatory bowel disease.
Reinshagen M; Von Tirpitz C
Minerva Med; 2004 Dec; 95(6):481-7. PubMed ID: 15785433
[TBL] [Abstract][Full Text] [Related]
20. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.
Krela-Kaźmierczak I; Kaczmarek-Ryś M; Szymczak A; Michalak M; Skrzypczak-Zielińska M; Drwęska-Matelska N; Marcinkowska M; Eder P; Łykowska-Szuber L; Wysocka E; Linke K; Słomski R
Calcif Tissue Int; 2016 Dec; 99(6):616-624. PubMed ID: 27639566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
